The in vivo response of invariant natural killer T cells to glycolipid antigens.
about
Natural killer T cells in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitisPD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cellsUpdate on the immunological pathway of negative regulation in acute insults and sepsisImpact of bacteria on the phenotype, functions, and therapeutic activities of invariant NKT cells in mice.Activated invariant NKT cells control central nervous system autoimmunity in a mechanism that involves myeloid-derived suppressor cells.Invariant natural killer T cells: bridging innate and adaptive immunity.Natural killer T cells in health and disease.Glycolipid ligands of invariant natural killer T cells as vaccine adjuvantsImmunopathology of hepatitis B virus infection.Invariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigens.Mesenchymal stromal cells: a key player in 'innate tolerance'?Natural Killer T Cells in Cancer Immunotherapyα-Galactosylceramide protects mice from lethal Coxsackievirus B3 infection and subsequent myocarditis.Invariant NKT cells increase lipopolysacchride-induced pregnancy loss by a mechanism involving Th1 and Th17 responses.A Call to Arms: Quest for a Cryptococcal Vaccine.The Role of Natural Killer T Cells in Cancer-A Phenotypical and Functional Approach.Therapeutic Potential of Invariant Natural Killer T Cells in Autoimmunity.
P2860
Q28085038-C36197B5-17AB-4F3B-AE5A-2A5839C6DE50Q30488777-B60A4E1F-D1F0-4AF2-89FE-610D3E0C9B4BQ36079845-2A1211D9-E0B8-4F90-A768-3C7255B15A89Q36597496-E2DB0BDA-CB2C-4634-A751-186762C3D6BBQ36625312-AD6F0DE0-DC9B-4B80-9FC6-E711D940CCF4Q36739848-E5BB1106-B699-41C8-BF4B-013FB3FC0495Q36765720-E16937AA-1CCC-4F08-9A10-DCCE3CD8E1D9Q37187603-F5F88BAF-07C1-486D-B529-54AB2B9C6FB1Q37344233-09929651-65F1-4D3A-9D45-6CD2A6713EDFQ37822744-581B32CE-A4EB-4EB4-899C-D0759F444FD5Q38026931-B1B2AAB8-DB16-4717-B64B-39E5A1AA906BQ42078314-49370538-0207-46B0-93B4-FD7E966C8A1BQ42931110-275E751B-484D-4EE3-B4EB-D9D7F96C5172Q43917376-4E4FC8AC-DD6D-4565-8422-18389EABBFA3Q50149203-663682BE-0C8B-460D-9A3D-2338DBDD5DE8Q55094012-AF027810-9BBD-4E43-945B-FFBFFCAA0119Q55280646-06206612-F037-4B2C-9A02-63816527FDA8
P2860
The in vivo response of invariant natural killer T cells to glycolipid antigens.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The in vivo response of invariant natural killer T cells to glycolipid antigens.
@ast
The in vivo response of invariant natural killer T cells to glycolipid antigens.
@en
type
label
The in vivo response of invariant natural killer T cells to glycolipid antigens.
@ast
The in vivo response of invariant natural killer T cells to glycolipid antigens.
@en
prefLabel
The in vivo response of invariant natural killer T cells to glycolipid antigens.
@ast
The in vivo response of invariant natural killer T cells to glycolipid antigens.
@en
P2860
P1476
The in vivo response of invariant natural killer T cells to glycolipid antigens.
@en
P2093
Saif Lalani
Vrajesh V Parekh
P2860
P356
10.1080/08830180601070179
P50
P577
2007-01-01T00:00:00Z